Journal of Clinical Microbiology · 1990 · 314 citations · 12 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyMycologyAntibiotic ResistanceAntifungal PharmacologyAntifungal ResistanceAntifungal TherapyFungal InfectionsFungal PathogenesisAntifungal Drug ResistanceDisseminated Fungal InfectionDrug Resistance Pattern AnalysisFungal Drug ResistanceIn Vitro Drug Susceptibility TestingLethal Concentration MedianResistance In Clinical IsolatesTolerance To Antifungal Agents
Trichosporon beigelii caused fatal disseminated infections that were resistant to amphotericin B in two granulocytopenic patients. In vitro susceptibility studies demonstrated that both index strains of T. beigelii were inhibited but not killed by amphotericin B at achievable concentrations in serum. The minimum lethal concentration for both isolates was greater than or equal to 18 micrograms/ml. Five of seven other isolates were found to have a similar pattern of amphotericin B resistance. The fact that the minimum lethal concentration of T. beigelii was many times greater than its MIC was consistent with a resistance pattern of tolerance. We concluded that T. beigelii may be resistant in vitro to amphotericin B and that this in vitro resistance was correlated with refractory, disseminated trichosporonosis in granulocytopenic patients. T. beigelii should be included in the expanding list of amphotericin B-resistant fungi.
12
Trichosporon beigelii infection: a review.
Jennifer Hoy, Kuo Ching Hsu, Kenneth V. I. Rolston et al. · PubMed · 1987 · 165 citations